important information for the patient.
Neorelium contains the active substance diazepam, which belongs to a group of medicines called benzodiazepines. Diazepam has anxiolytic, sedative, anticonvulsant, and muscle relaxant properties. It is used:
If the patient has:
General information about the effects observed with benzodiazepines and other medicines with similar effects to benzodiazepines, which should be taken into account when taking Neorelium.
Tolerance may develop after taking Neorelium for several weeks, reducing its effectiveness.
Dependence may occur with long-term use of Neorelium, leading to psychological and physical dependence. The risk of dependence increases with the dose and duration of treatment and is higher in patients with a history of substance abuse or personality disorders.
Withdrawal symptoms may occur when Neorelium is stopped abruptly, such as headaches, muscle pain, increased anxiety, tension, agitation, restlessness, disorientation, sleep disturbances, and irritability. In severe cases, more serious symptoms may occur, including loss of reality, personality disorders, hypersensitivity to sound, touch, light, noise, tingling, and numbness of limbs, hallucinations, and delusions.
A rebound effect and anxiety may occur when Neorelium is discontinued, with a transient recurrence of the symptoms that led to its use. These symptoms are often accompanied by mood changes, anxiety, sleep disturbances, and insomnia. To minimize the risk of these symptoms, it is recommended to gradually reduce the dose of Neorelium.
Anterograde amnesia (inability to remember events after taking the medicine) may occur, especially when Neorelium is taken in high doses. This condition usually occurs within a few hours of taking the medicine.
Psychological and paradoxical reactions, such as anxiety, agitation, irritability, aggression, anger, and rage, may occur, especially in children and the elderly.
In case of such symptoms, the doctor should be contacted immediately.
Special patient groups:
Children: Neorelium should be used with caution in children and only for a short period, as the safety and efficacy of the medicine have not been established in this age group.
Elderly patients: Neorelium should be used with caution in elderly patients, as they may be more sensitive to the medicine. The dose should be reduced, and the patient should be monitored closely for signs of dependence or withdrawal symptoms.
Patients with liver or kidney impairment: Neorelium should be used with caution in patients with liver or kidney impairment, as the medicine may accumulate in the body and increase the risk of side effects.
Patients with depression: Neorelium should be used with caution in patients with depression, as it may worsen the symptoms of depression.
Patients with a history of substance abuse: Neorelium should be used with caution in patients with a history of substance abuse, as they may be more likely to develop dependence on the medicine.
The doctor should be informed about all medicines being taken, including those that are about to be taken.
This is especially important if the patient is taking any of the following medicines:
If the doctor prescribes Neorelium with opioids, the dose and duration of concomitant treatment should be limited. The patient should inform the doctor about all opioid medicines being taken and follow the doctor's instructions for dosing. It may be helpful to inform friends or family members to be aware of the possibility of these symptoms. If such symptoms occur, the doctor should be contacted.
If the patient is pregnant, breastfeeding, or planning to become pregnant, they should consult their doctor or pharmacist before taking Neorelium.
Neorelium should not be taken during pregnancy.
Neorelium passes into breast milk. If treatment is necessary, breastfeeding should be discontinued.
During treatment with Neorelium and for 24 hours after stopping treatment, the patient should not drive or operate machinery.
The ability to drive or operate machinery may be impaired due to the possibility of sedation, impaired concentration, or other side effects that may reduce concentration (see section 4; Possible side effects).
If the patient has previously been diagnosed with intolerance to some sugars, they should consult their doctor before taking Neorelium.
Neorelium contains less than 1 mmol (23 mg) of sodium per tablet, which means that the medicine is considered "sodium-free".
Neorelium should always be taken as directed by the doctor.
In case of doubts, the doctor should be consulted.
Recommended dose:
For anxiety, increased muscle tone, or as an anticonvulsant - 1 mg to 2.5 mg 3 to 4 times a day or 0.12 mg to 0.8 mg/kg body weight or 3.5 mg to 24 mg/m2 body surface area per day in 3 to 4 divided doses, then the dose can be gradually increased depending on efficacy and side effects.
The doctor will determine the dosage individually for each patient, depending on the degree of organ dysfunction.
Elderly patients are more sensitive to medicines that act on the central nervous system. When taking Neorelium in this population, the smallest effective dose should be used. The dose should not exceed half of the recommended dose for adults.
If the patient feels that the effect of the medicine is too strong or too weak, they should consult their doctor.
The duration of treatment is determined by the doctor.
Neorelium tablets should be taken orally, with a small amount of water.
The doctor will start treatment with the lowest effective dose and gradually increase it if necessary.
Symptoms of diazepam overdose are impaired consciousness, sedation, confusion, slurred speech. In severe cases of poisoning, the following may occur: ataxia, hypotension, muscle weakness, respiratory depression, coma, and even death.
In case of overdose, the doctor or the nearest emergency department should be contacted immediately. The patient should take the medicine in its original packaging so that the medical staff can accurately determine which medicine was taken.
If the patient forgets to take a dose, they should take the next dose as soon as possible. However, if it is close to the time of the next dose, the missed dose should be skipped and the next dose taken as directed. If the patient forgets to take two or more doses, they should consult their doctor.
The patient should not take a double dose to make up for a missed dose.
Treatment with Neorelium should not be stopped unless advised by the doctor. It is possible that the symptoms of the disease will recur. If the doctor decides to stop treatment, the dose of Neorelium should be gradually reduced over several days.
In case of doubts about taking the medicine, the doctor should be consulted.
Like all medicines, Neorelium can cause side effects, although not everybody gets them.
If any of the following side effects occur, the doctor should be informed immediatelyor the patient should go to the nearest emergency department:
If any side effects occur, including any side effects not listed in this leaflet, the doctor, pharmacist, or nurse should be informed. Side effects can be reported directly to the Department of Pharmacovigilance of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products.
The medicine should be stored out of sight and reach of children.
Store in a temperature below 25°C. Protect from light and moisture.
Do not use the medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. The pharmacist should be asked how to dispose of medicines that are no longer needed. This will help protect the environment.
The active substance of Neorelium is diazepam. One coated tablet contains 5 mg of diazepam.
The other ingredients are: potato starch, sodium carboxymethylcellulose (type A), gelatin, polysorbate 80, quinoline yellow (E 104), talc, magnesium stearate, lactose monohydrate, hypromellose, macrogol 6000.
Yellow, round, biconvex coated tablets.
Packaging:20 coated tablets.
Tarchomińskie Zakłady Farmaceutyczne "Polfa" Spółka Akcyjna
ul. A. Fleminga 2
03-176 Warszawa
Phone: 22 811-18-14
To obtain more detailed information, please contact the representative of the marketing authorization holder.
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.